Methenamine Hippurate Tablet
Product Images NDC 72603-816

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 72603-816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (1 g (100 Tablets Bottle))

Package Label.principal Display Panel (1 g (100 Tablets Bottle))
Each tablet contains Methenamine hippurate 1g. Manufactured by Northstar Rx LLC for USP in Memphis, TN. The dosage and administration details can be found in the package insert. Aurobindo Pharma Limited in India also produces the tablets. It is important to keep this medication out of reach of children and store it in a well-closed, light-resistant container at 20° to 25°C. The tablets are a product of India and should be dispensed by a pharmacist. H|p purate tablets are labeled with a warning, a license number, and an expiration date. Additional information such as GTIN, Serial Number, and LOT will be printed during packing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.